165 related articles for article (PubMed ID: 12606553)
1. Thrombin induces nitric-oxide synthase via Galpha12/13-coupled protein kinase C-dependent I-kappaBalpha phosphorylation and JNK-mediated I-kappaBalpha degradation.
Kang KW; Choi SY; Cho MK; Lee CH; Kim SG
J Biol Chem; 2003 May; 278(19):17368-78. PubMed ID: 12606553
[TBL] [Abstract][Full Text] [Related]
2. Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways.
Chan ED; Morris KR; Belisle JT; Hill P; Remigio LK; Brennan PJ; Riches DW
Infect Immun; 2001 Apr; 69(4):2001-10. PubMed ID: 11254551
[TBL] [Abstract][Full Text] [Related]
3. Distinct involvement of NF-kappaB and p38 mitogen-activated protein kinase pathways in serum deprivation-mediated stimulation of inducible nitric oxide synthase and its inhibition by 4-hydroxynonenal.
Liu W; Kato M; Itoigawa M; Murakami H; Yajima M; Wu J; Ishikawa N; Nakashima I
J Cell Biochem; 2001 Aug 1-9; 83(2):271-80. PubMed ID: 11573244
[TBL] [Abstract][Full Text] [Related]
4. Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhances NF-kappaB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65/p300 binding.
Darieva Z; Lasunskaia EB; Campos MN; Kipnis TL; Da Silva WD
J Leukoc Biol; 2004 Apr; 75(4):689-97. PubMed ID: 14742634
[TBL] [Abstract][Full Text] [Related]
5. Isoeugenol suppression of inducible nitric oxide synthase expression is mediated by down-regulation of NF-kappaB, ERK1/2, and p38 kinase.
Choi CY; Park KR; Lee JH; Jeon YJ; Liu KH; Oh S; Kim DE; Yea SS
Eur J Pharmacol; 2007 Dec; 576(1-3):151-9. PubMed ID: 17698059
[TBL] [Abstract][Full Text] [Related]
6. Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells.
Guan Z; Buckman SY; Springer LD; Morrison AR
J Biol Chem; 1999 Dec; 274(51):36200-6. PubMed ID: 10593906
[TBL] [Abstract][Full Text] [Related]
7. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Hirata Y
J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
[TBL] [Abstract][Full Text] [Related]
8. Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes.
Hua LL; Zhao ML; Cosenza M; Kim MO; Huang H; Tanowitz HB; Brosnan CF; Lee SC
J Neuroimmunol; 2002 May; 126(1-2):180-9. PubMed ID: 12020969
[TBL] [Abstract][Full Text] [Related]
9. Thrombin induces inducible nitric oxide synthase expression via the MAPK, MSK1, and NF-κB signaling pathways in alveolar macrophages.
Lin CC; Shih CH; Yang YL; Bien MY; Lin CH; Yu MC; Sureshbabu M; Chen BC
Eur J Pharmacol; 2011 Dec; 672(1-3):180-7. PubMed ID: 22004609
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase.
Kim ND; Kim EM; Kang KW; Cho MK; Choi SY; Kim SG
Br J Pharmacol; 2003 Oct; 140(4):661-70. PubMed ID: 14534150
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line.
Chan ED; Riches DW
Am J Physiol Cell Physiol; 2001 Mar; 280(3):C441-50. PubMed ID: 11171562
[TBL] [Abstract][Full Text] [Related]
12. (E)-3-(3,4-Dimethoxyphenyl)-1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)prop-2-en-1-one ameliorates the collagen-arthritis via blocking ERK/JNK and NF-κB signaling pathway.
Li X; Peng F; Xie C; Wu W; Han X; Chen L
Int Immunopharmacol; 2013 Dec; 17(4):1125-33. PubMed ID: 24135236
[TBL] [Abstract][Full Text] [Related]
13. 8-Prenylkaempferol suppresses inducible nitric oxide synthase expression through interfering with JNK-mediated AP-1 pathway in murine macrophages.
Chen CC; Tsai PC; Wei BL; Chiou WF
Eur J Pharmacol; 2008 Aug; 590(1-3):430-6. PubMed ID: 18579129
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation.
Lee AK; Sung SH; Kim YC; Kim SG
Br J Pharmacol; 2003 May; 139(1):11-20. PubMed ID: 12746218
[TBL] [Abstract][Full Text] [Related]
15. Group IIA secretory phospholipase A(2) stimulates inducible nitric oxide synthase expression via ERK and NF-kappaB in macrophages.
Baek SH; Lim JH; Park DW; Kim SY; Lee YH; Kim JR; Kim JH
Eur J Immunol; 2001 Sep; 31(9):2709-17. PubMed ID: 11536169
[TBL] [Abstract][Full Text] [Related]
16. Role of mitogen-activated protein kinases in peptidoglycan-induced expression of inducible nitric oxide synthase and nitric oxide in mouse peritoneal macrophages: extracellular signal-related kinase, a negative regulator.
Bhatt KH; Sodhi A; Chakraborty R
Clin Vaccine Immunol; 2011 Jun; 18(6):994-1001. PubMed ID: 21450974
[TBL] [Abstract][Full Text] [Related]
17. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.
Chen CC; Wang JK
Mol Pharmacol; 1999 Mar; 55(3):481-8. PubMed ID: 10051531
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB.
Marcus JS; Karackattu SL; Fleegal MA; Sumners C
Glia; 2003 Jan; 41(2):152-60. PubMed ID: 12509805
[TBL] [Abstract][Full Text] [Related]
19. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation.
Zhong HM; Ding QH; Chen WP; Luo RB
Int Immunopharmacol; 2013 Oct; 17(2):329-35. PubMed ID: 23856614
[TBL] [Abstract][Full Text] [Related]
20. Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-kappaB/Rel in lipopolysaccharide-stimulated macrophages.
Jeon YJ; Kim YK; Lee M; Park SM; Han SB; Kim HM
J Pharmacol Exp Ther; 2000 Aug; 294(2):548-54. PubMed ID: 10900231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
